• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Fischer Imaging reports positive 2Q results

Article

X-ray and mammography equipment vendor Fischer Imaging reported revenue of $19.8 million for the second quarter, ended June 30, 2004, a 64% increase over revenue of $12.1 million for the same period in 2003. Net income for the 2004 second quarter was

X-ray and mammography equipment vendor Fischer Imaging reported revenue of $19.8 million for the second quarter, ended June 30, 2004, a 64% increase over revenue of $12.1 million for the same period in 2003. Net income for the 2004 second quarter was $3.2 million compared with a net loss of $2.4 million in the comparable 2003 period. Results were bolstered, however, by an amended 2002 patent settlement agreement. The amendment provided a one-time payment totaling $4.3 million in lieu of six remaining $0.9 million payments that were due annually through 2010. The gross margin on product sales was 28.5% in the second quarter of 2004, down from 33.1% in the second quarter of 2003. The negative service margin was primarily a result of increased parts usage associated with installed SenoScan systems. The company's quality improvement initiatives and eventual contract maintenance revenue increases are expected to favorably impact both product and service margins over time.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.